Brain-derived neurotrophic factor but not beta-secretase 1, vascular endothelial growth factor, glial fibrillary acidic protein and interleukin-1β correlate with cognitive impairment in adult persons with epilepsy: a cross-sectional single-center study from India

ObjectivesThis study aims to evaluate cognitive impairment utilizing the Montreal Cognitive Assessment (MoCA) scale, while also exploring the correlation between cognitive impairment and various serum biomarkers, including Brain-derived neurotrophic factor (BDNF), Beta Secretase-1 (BACE1), Vascular...

Full description

Saved in:
Bibliographic Details
Main Authors: Kamini Bhavsar, Manjari Tripathi, Jyotirmoy Banerjee, Arpna Srivastava, Nidhi, Shivam Pandey, Divya Vohora
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1540915/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850212410105790464
author Kamini Bhavsar
Manjari Tripathi
Jyotirmoy Banerjee
Arpna Srivastava
Nidhi
Shivam Pandey
Divya Vohora
author_facet Kamini Bhavsar
Manjari Tripathi
Jyotirmoy Banerjee
Arpna Srivastava
Nidhi
Shivam Pandey
Divya Vohora
author_sort Kamini Bhavsar
collection DOAJ
description ObjectivesThis study aims to evaluate cognitive impairment utilizing the Montreal Cognitive Assessment (MoCA) scale, while also exploring the correlation between cognitive impairment and various serum biomarkers, including Brain-derived neurotrophic factor (BDNF), Beta Secretase-1 (BACE1), Vascular Endothelial Growth Factors (VEGF), Glial fibrillary acidic protein (GFAP), and Interleukin-1 (IL-1β) in adults living with epilepsy.MethodsIn this study, 74 participants aged between 18 and 50 years, who were visiting neurology outpatient consultations, were included. The cognitive assessment was executed using the MoCA test. Serum levels of BDNF, BACE1, VEGF, GFAP, and IL-1β were evaluated through ELISA in patients with and without cognitive impairments. To determine the association between MoCA scores and the biomarkers, both Spearman and Pearson correlation analyses, as well as linear regression, were conducted.ResultsAmong the 74 PWE, 61 exhibited cognitive impairment as determined by the MoCA assessment. Noteworthy alterations were detected across various MoCA subscales, encompassing visuospatial and executive functions, attention, language, abstraction, and delayed recall, with statistical significance established (p < 0.05). Furthermore, it was revealed that those in the cognitively impaired group presented with reduced serum BDNF levels (p < 0.05). It is important to highlight that no substantial differences were identified in the serum concentrations of BACE-1, VEGF, GFAP, and IL-1β. A moderate and statistically significant correlation was established between BDNF and the Total MoCA score (p < 0.05), in addition to BDNF’s relationship with Visuospatial & Executive function (p < 0.05). In the context of regression analysis, BDNF demonstrated a significant association to the Total MoCA score (p < 0.05), a connection that persisted as significant even when adjusted for confounding factors.ConclusionWe conclude that adult PWE in India demonstrate a significant cognitive impairment. Further, our findings indicate that BDNF may serve as a potential biomarker for evaluating cognitive impairment in adult PWE. Further longitudinal, prospective and multi-center studies are required to confirm the same.
format Article
id doaj-art-a735b26cda5547068ae9c2e1a8f2076d
institution OA Journals
issn 1664-2295
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj-art-a735b26cda5547068ae9c2e1a8f2076d2025-08-20T02:09:21ZengFrontiers Media S.A.Frontiers in Neurology1664-22952025-04-011610.3389/fneur.2025.15409151540915Brain-derived neurotrophic factor but not beta-secretase 1, vascular endothelial growth factor, glial fibrillary acidic protein and interleukin-1β correlate with cognitive impairment in adult persons with epilepsy: a cross-sectional single-center study from IndiaKamini Bhavsar0Manjari Tripathi1Jyotirmoy Banerjee2Arpna Srivastava3 Nidhi4Shivam Pandey5Divya Vohora6Department of Pharmacology, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard, New Delhi, IndiaDepartment of Neurology, All India Institute of Medical Science (AIIMS), New Delhi, IndiaDepartment of Biophysics, All India Institute of Medical Science (AIIMS), New Delhi, IndiaDepartment of Neurology, All India Institute of Medical Science (AIIMS), New Delhi, IndiaSchool of Chemical and Life Sciences (SCLS), Jamia Hamdard, New Delhi, IndiaDepartment of Biostatistics, All India Institute of Medical Science (AIIMS), New Delhi, IndiaDepartment of Pharmacology, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard, New Delhi, IndiaObjectivesThis study aims to evaluate cognitive impairment utilizing the Montreal Cognitive Assessment (MoCA) scale, while also exploring the correlation between cognitive impairment and various serum biomarkers, including Brain-derived neurotrophic factor (BDNF), Beta Secretase-1 (BACE1), Vascular Endothelial Growth Factors (VEGF), Glial fibrillary acidic protein (GFAP), and Interleukin-1 (IL-1β) in adults living with epilepsy.MethodsIn this study, 74 participants aged between 18 and 50 years, who were visiting neurology outpatient consultations, were included. The cognitive assessment was executed using the MoCA test. Serum levels of BDNF, BACE1, VEGF, GFAP, and IL-1β were evaluated through ELISA in patients with and without cognitive impairments. To determine the association between MoCA scores and the biomarkers, both Spearman and Pearson correlation analyses, as well as linear regression, were conducted.ResultsAmong the 74 PWE, 61 exhibited cognitive impairment as determined by the MoCA assessment. Noteworthy alterations were detected across various MoCA subscales, encompassing visuospatial and executive functions, attention, language, abstraction, and delayed recall, with statistical significance established (p < 0.05). Furthermore, it was revealed that those in the cognitively impaired group presented with reduced serum BDNF levels (p < 0.05). It is important to highlight that no substantial differences were identified in the serum concentrations of BACE-1, VEGF, GFAP, and IL-1β. A moderate and statistically significant correlation was established between BDNF and the Total MoCA score (p < 0.05), in addition to BDNF’s relationship with Visuospatial & Executive function (p < 0.05). In the context of regression analysis, BDNF demonstrated a significant association to the Total MoCA score (p < 0.05), a connection that persisted as significant even when adjusted for confounding factors.ConclusionWe conclude that adult PWE in India demonstrate a significant cognitive impairment. Further, our findings indicate that BDNF may serve as a potential biomarker for evaluating cognitive impairment in adult PWE. Further longitudinal, prospective and multi-center studies are required to confirm the same.https://www.frontiersin.org/articles/10.3389/fneur.2025.1540915/fullMontreal Cognitive Assessment (MoCA)brain-derived neurotrophic factorbeta secretase-1vascular endothelial growth factorglial fibrillary acidic proteininterleukin-1β
spellingShingle Kamini Bhavsar
Manjari Tripathi
Jyotirmoy Banerjee
Arpna Srivastava
Nidhi
Shivam Pandey
Divya Vohora
Brain-derived neurotrophic factor but not beta-secretase 1, vascular endothelial growth factor, glial fibrillary acidic protein and interleukin-1β correlate with cognitive impairment in adult persons with epilepsy: a cross-sectional single-center study from India
Frontiers in Neurology
Montreal Cognitive Assessment (MoCA)
brain-derived neurotrophic factor
beta secretase-1
vascular endothelial growth factor
glial fibrillary acidic protein
interleukin-1β
title Brain-derived neurotrophic factor but not beta-secretase 1, vascular endothelial growth factor, glial fibrillary acidic protein and interleukin-1β correlate with cognitive impairment in adult persons with epilepsy: a cross-sectional single-center study from India
title_full Brain-derived neurotrophic factor but not beta-secretase 1, vascular endothelial growth factor, glial fibrillary acidic protein and interleukin-1β correlate with cognitive impairment in adult persons with epilepsy: a cross-sectional single-center study from India
title_fullStr Brain-derived neurotrophic factor but not beta-secretase 1, vascular endothelial growth factor, glial fibrillary acidic protein and interleukin-1β correlate with cognitive impairment in adult persons with epilepsy: a cross-sectional single-center study from India
title_full_unstemmed Brain-derived neurotrophic factor but not beta-secretase 1, vascular endothelial growth factor, glial fibrillary acidic protein and interleukin-1β correlate with cognitive impairment in adult persons with epilepsy: a cross-sectional single-center study from India
title_short Brain-derived neurotrophic factor but not beta-secretase 1, vascular endothelial growth factor, glial fibrillary acidic protein and interleukin-1β correlate with cognitive impairment in adult persons with epilepsy: a cross-sectional single-center study from India
title_sort brain derived neurotrophic factor but not beta secretase 1 vascular endothelial growth factor glial fibrillary acidic protein and interleukin 1β correlate with cognitive impairment in adult persons with epilepsy a cross sectional single center study from india
topic Montreal Cognitive Assessment (MoCA)
brain-derived neurotrophic factor
beta secretase-1
vascular endothelial growth factor
glial fibrillary acidic protein
interleukin-1β
url https://www.frontiersin.org/articles/10.3389/fneur.2025.1540915/full
work_keys_str_mv AT kaminibhavsar brainderivedneurotrophicfactorbutnotbetasecretase1vascularendothelialgrowthfactorglialfibrillaryacidicproteinandinterleukin1bcorrelatewithcognitiveimpairmentinadultpersonswithepilepsyacrosssectionalsinglecenterstudyfromindia
AT manjaritripathi brainderivedneurotrophicfactorbutnotbetasecretase1vascularendothelialgrowthfactorglialfibrillaryacidicproteinandinterleukin1bcorrelatewithcognitiveimpairmentinadultpersonswithepilepsyacrosssectionalsinglecenterstudyfromindia
AT jyotirmoybanerjee brainderivedneurotrophicfactorbutnotbetasecretase1vascularendothelialgrowthfactorglialfibrillaryacidicproteinandinterleukin1bcorrelatewithcognitiveimpairmentinadultpersonswithepilepsyacrosssectionalsinglecenterstudyfromindia
AT arpnasrivastava brainderivedneurotrophicfactorbutnotbetasecretase1vascularendothelialgrowthfactorglialfibrillaryacidicproteinandinterleukin1bcorrelatewithcognitiveimpairmentinadultpersonswithepilepsyacrosssectionalsinglecenterstudyfromindia
AT nidhi brainderivedneurotrophicfactorbutnotbetasecretase1vascularendothelialgrowthfactorglialfibrillaryacidicproteinandinterleukin1bcorrelatewithcognitiveimpairmentinadultpersonswithepilepsyacrosssectionalsinglecenterstudyfromindia
AT shivampandey brainderivedneurotrophicfactorbutnotbetasecretase1vascularendothelialgrowthfactorglialfibrillaryacidicproteinandinterleukin1bcorrelatewithcognitiveimpairmentinadultpersonswithepilepsyacrosssectionalsinglecenterstudyfromindia
AT divyavohora brainderivedneurotrophicfactorbutnotbetasecretase1vascularendothelialgrowthfactorglialfibrillaryacidicproteinandinterleukin1bcorrelatewithcognitiveimpairmentinadultpersonswithepilepsyacrosssectionalsinglecenterstudyfromindia